NCT00579683View on ClinicalTrials.gov

Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

228

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)
Interventions
OTHER

Tumor core biopsy for RNA isolation

RNA isolation will be carried out using approximately 25 mg of gross tissue from these tumor specimens.

Trial Locations (5)

10065

Memorial Sloan Kettering Cancer Center, New York

10591

Memoral Sloan Kettering Cancer Center at Phelps, Sleepy Hollow

11725

Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack

Unknown

Memoral Sloan Kettering Cancer Center, Basking Ridge

Memorial Sloan-Kettering at Mercy Medical Center, Rockville Centre

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00579683 - Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer | Biotech Hunter | Biotech Hunter